Infanrix-Polio+hib

Haemophilus Type B Conjugate Vaccine (Tetanus Toxoid Conjugate), the active ingredient in Infanrix-Polio+hib, is a vaccine presented as an injectable solution for intramuscular use. It prevents diphtheria, tetanus, pertussis, Haemophilus influenzae type b disease, and poliomyelitis in infants and young children.

GNH USA supplies Infanrix-Polio+hib as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Infanrix-Polio+hib is a combination vaccine that targets several bacterial and viral agents responsible for serious childhood diseases. - Diphtheria: induces protective antibodies that prevent diphtheria toxin effects. - Tetanus: stimulates immunity against tetanus neurotoxin. - Pertussis (whooping cough): generates antibodies to Bordetella pertussis antigens. - Haemophilus influenzae type b disease: provides conjugate‑induced protection against invasive Hib infections. - Poliomyelitis: elicits immunity to poliovirus types 1, 2 and 3, preventing paralytic polio.

Common Side Effects: - Pain at injection site: mild to moderate discomfort where the vaccine is administered. - Redness or swelling: localized inflammatory reaction. - Fever: transient rise in body temperature. - Irritability or crying: especially in infants. - Loss of appetite: temporary decrease in feeding. - Fatigue: mild tiredness after vaccination.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Seizures: rare neurologic events post‑vaccination. - High fever (≥40°C): may need antipyretic treatment. - Prolonged crying (≥3 hours): indicative of possible severe reaction. - Hypotonic‑hyporesponsive episode: sudden loss of muscle tone in infants. - Guillain‑Barré syndrome: extremely rare autoimmune neuropathy.

Infanrix-Polio+hib should be administered according to approved pediatric immunisation schedules. - Allergy: avoid if the patient has a known hypersensitivity to any vaccine component. - Medical conditions: consult a healthcare professional if the child is immunocompromised or has a severe acute illness. - Concurrent vaccines: follow recommended intervals when co‑administering with other vaccines. - Pregnancy: not indicated for use in pregnant women; defer vaccination until after delivery. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Vaccination may be influenced by other medical products. Major Interactions (Avoid): - Live attenuated vaccines: avoid administration within 4 weeks before or after this vaccine. - Immunoglobulin or blood products: may diminish the immune response if given concurrently. Moderate Interactions (Monitor Closely): - Antipyretics (e.g., acetaminophen): can mask fever, monitor for underlying reactions. - Systemic corticosteroids: may blunt antibody production. - Other inactivated vaccines: generally safe but observe for additive local reactions. - Antibiotics: no significant interaction, but monitor for infection control.